13F History
Schedule 13D/G History
Ownership
Other Reports

ORBIMED ADVISORS LLC - Significant Ownership

Signature - Title: Sven H. Borho - Member
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by ORBIMED ADVISORS LLC.

Significant Ownership of ORBIMED ADVISORS LLC

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
TRAW	Traws Pharma, Inc.	Common Stock	19.9%	$1.83M		761K		ORBIMED ADVISORS LLC	Dec 31, 2024
PASG	Passage BIO, Inc.	Common Stock	12%	$4.2M		7.4M		ORBIMED ADVISORS LLC	Dec 20, 2024
CMPX	Compass Therapeutics, Inc.	COMMON STOCK	11%	$28.9M		15.2M		ORBIMED ADVISORS LLC	Apr 9, 2024
RAPT	RAPT Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.9%	$16M		13.1M		ORBIMED ADVISORS LLC	Dec 31, 2024
SION	Sionna Therapeutics, Inc.	Common Stock	8.4%	$42.8M		3.7M		ORBIMED ADVISORS LLC	Feb 10, 2025
FBRX	Forte Biosciences, Inc.	Common Stock, par value $0.001 per share	8%	$4.18M		510K		ORBIMED ADVISORS LLC	Dec 31, 2024
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Common Stock, par value $0.0001 per share	5.9%	$3.81M		718K		OrbiMed Capital LLC	Dec 31, 2024
IRON	Disc Medicine, Inc.	Common Stock	4.5%	$77.3M		1.56M		ORBIMED ADVISORS LLC	Mar 10, 2025
ADCT	ADC Therapeutics SA	Common Shares, par value CHF 0.08 per share	3.6%	$4.85M		3.44M		ORBIMED CAPITAL LLC	Dec 31, 2024
XTNT	Xtant Medical Holdings, Inc.	COMMON STOCK	0%	$0		0		ORBIMED ADVISORS LLC	Apr 10, 2025

Showing 1 to 10 of 10 entries

Schedules 13D/G Reported by ORBIMED ADVISORS LLC:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.